We first analyzed the expression of CD39, CD73 and CD103 in peripheral blood and non-cancerous lung (NCL) and tumor tissue of early untreated NSCLC using flow cytometry (figure 1A). The gene discussed is ENTPD1; the disease is non-small cell lung carcinoma.